NASDAQ: HSTM · Healthcare Information Services
HealthStream (HSTM) fair value: undervalued or overvalued?
As of 14 Nov 2026, Faircurve's model values HealthStream (HSTM) at $27.45 a share. The stock last closed at $27.68, which puts the model's fair value 0.8% below the price. On the model's bands that reads as Fairly valued.
Revalued . Price is the close of 16 Nov 2026. HealthStream, Inc.
The report adds the live price, the price chart, the next earnings date and the analysts' consensus. No account needed.
This week, in three parts
What happenedThe run of 14 Nov 2026 held the fair value at $27.45, within 1% of the run of 7 Nov 2026.
What the model makes of itThe price of $27.68 is 0.8% above it: Fairly valued, on a medium evidence grade.
What's nextNext report on 22 Feb 2027. The next weekly run is on Saturday 21 Nov 2026.
What price range does the model give HSTM?
The calibrated range for HSTM over 63 trading days is $21.95 to $32.61. There is no live options data for this stock, so the range is built from the fair value and calibrated weekly against realised prices (n = 13,250 past valuations, refreshed 14 Nov 2026). Ranges built this way held the price 60% of the time at this horizon.
The model's own simulated range, from the 20th to the 80th percentile of its runs, is $22.52 to $33.41. In 47% of the simulations the fair value came out above the price the model ran on.
Faircurve Insights · 14 Nov 2026
HealthStream, Inc. is a company that delivers specialised workforce and provider solutions to healthcare organisations across the United States. It was established in 1990 and is headquartered in Nashville, Tennessee.
On 14 Nov 2026, Faircurve's model gave HealthStream a fair value of $27.45 a share, the midpoint of 2,000 simulations. The previous run, on 7 Nov 2026, gave $27.30, so the fair value moved +0.5%. The calibrated range over 63 trading days is $21.95 to $32.61. It is built from the fair value, as there is no live options data for the stock. It is calibrated weekly against realised prices, using 13,250 past valuations. Ranges built this way held the price 60% of the time at this horizon. The evidence grade is Medium. The grade reflects how complete the inputs are, how many comparable companies there are and how closely they agree, and how wide the range of outcomes is. It does not test whether the fair value is right.
HealthStream scores 71 out of 100 on the model's overall quality measure, a composite of six factors scored against comparable companies. Earnings quality scores 80, with FCF / net income at 2.00x. Stability scores 91, with five-year EBITDA margin downside volatility at 1.5 pts against a peer median of 11.5 pts. Capital discipline scores lowest at 44, with net buybacks / market value at 1.7% against a peer median of 3.6%. The model compares the company with Omnicell, Inc., Certara, Inc., Privia Health Group, Inc., Waystar Holding Corp. and Doximity, Inc.
Written from the figures on this page for the 14 Nov 2026 valuation and checked by rule before publishing: every number is one printed here, no forecast, no instruction. The price, the gap and the verdict are the page's own and change daily. Not a recommendation.
The Global Pulse
Faircurve's note after each US session, in your inbox. No account needed.
When does HSTM report earnings, and how has the stock reacted?
HealthStream's next earnings report is scheduled for 22 Feb 2027. Companies can move their dates.
Around its last 8 reports: what the options market priced, and what followed
Each move runs from the last close before the report to the first close after it, so it covers companies that report before the open and after the close. The median size across HSTM's last 8 reports, ignoring direction, was 5.9%.
How does HSTM score on business quality?
HealthStream's overall quality score is 71 out of 100. Each factor below is a score against comparable companies, not a percentile of the metric beside it.
| Factor | Score (0 to 100) | Headline measure | Peer median |
|---|---|---|---|
| ProfitabilityReturn on invested capital against the peer group, with a bonus for an improving trend. | 69 | 5.4%ROIC | -3.1% |
| Earnings qualityHow much of reported profit is cash: free cash flow to net income, and the accrual ratio (the share of earnings that is not cash). | 80 | 2.00xFCF / net income | |
| Growth qualityTrailing revenue growth, forward growth from consensus, and the direction of analysts' rating changes. | 58 | 4.3%Revenue growth, trailing | -2.9% |
| Capital disciplineReinvestment efficiency (capital spending per unit of revenue) and net buybacks. | 44 | 1.7%Net buybacks / market value | 3.6% |
| Balance sheetNet debt to EBITDA and interest coverage. | 91 | -0.65xNet debt / EBITDA | |
| StabilityDownside volatility of the EBITDA margin over the last five years. | 91 | 1.5 ptsEBITDA margin downside volatility, 5y | 11.5 pts |
How does HSTM compare with similar companies?
The companies in healthcare information services closest to HealthStream in market value, each on the same model and the same date.
| Company | Last close | Model fair value | Gap | Model verdict |
|---|---|---|---|---|
| OMCL Omnicell, Inc. | $35.44 | $37.58 | +6.0% | Fairly valued |
| CERT Certara, Inc. | $11.39 | $11.49 | +0.9% | Fairly valued |
| PRVA Privia Health Group, Inc. | $25.26 | $21.92 | -13.2% | Overvalued |
| WAY Waystar Holding Corp. | $28.11 | $30.05 | +6.9% | Fairly valued |
| DOCS Doximity, Inc. | $32.77 | $32.13 | -2.0% | Fairly valued |
| HQY HealthEquity, Inc. | $104.58 | $104.84 | +0.2% | Low evidence grade |
| BTSG BrightSpring Health Services, Inc. Common Stock | $71.37 | $68.74 | -3.7% | Low evidence grade |
What the comparable companies' multiples alone would give for HSTM, the peer-implied price, is $25.03 a share on this run. The fair value weighs that against the company's own multiple.
All healthcare information services stocks ranked by gap to fair value
HealthStream at a glance
HealthStream, Inc., established in 1990 and headquartered in Nashville, Tennessee, delivers specialized workforce and provider solutions to healthcare organizations throughout the United States.
- Market value
- $856M
- Sector
- Healthcare
- Industry
- Healthcare Information Services
- Revenue expected, next twelve months
- $345M
- Consensus revenue growth, next fiscal year
- +9.2%
- Analysts with estimates
- 3
- Beta to the US market
- 0.32
- First valued by Faircurve
- 11 Jul 2026
At the close of 16 Nov 2026, 56.8% of the 1,085 graded US stocks the model covers traded below the model's fair value. HSTM was not among them.
How the fair value is worked out: the model prices HealthStream on the value of the whole business, debt included, against the operating profit analysts expect next year (forward EV/EBITDA), runs 2,000 simulations across its inputs and takes the midpoint. The full method is documented here.
What changed in the latest valuation?
On 7 Nov 2026 the model's fair value for HSTM was $27.30. As of 14 Nov 2026 it is $27.45, a change of +0.5%. The model revalues every stock it covers each week, and again after an earnings report.
Questions about HealthStream's valuation
Is HealthStream stock undervalued or overvalued?
On Faircurve's model, HSTM reads as Fairly valued as of 14 Nov 2026. The model's fair value is $27.45 a share against a last close of $27.68, a gap of -0.8%.
What is HSTM's fair value?
$27.45 a share as of 14 Nov 2026, the midpoint of 2,000 simulations. The model's own 20th to 80th percentile range is $22.52 to $33.41.
What price range does the model give HSTM?
$21.95 to $32.61 over 63 trading days. Ranges built this way held the price 60% of the time across 13,250 past valuations, refreshed 14 Nov 2026.
When does HealthStream report earnings next?
The next report is scheduled for 22 Feb 2027. Companies can move their dates.
How much has HSTM moved on past earnings reports?
Across its last 8 reports the median two session move was 5.9%, ignoring direction. The largest was +17.6% around the report of 4 May 2026.
How confident is the model in this valuation?
The model's evidence grade for HSTM is medium. The grade looks at how complete the inputs are, how many comparable companies there are and how closely they agree, and how wide the range of outcomes is. It is not a probability that the fair value is right, or that the price reaches it.
The model's own ideas on HSTM
The model holds no idea open on HSTM today. Signed-in readers see the rule each idea runs on, the floor and the exit level the model set and its time limit, and the model's closed ideas on HSTM with their outcomes. A free account is enough.